Back to Health

Who Should Avoid Cobicistat?

Who Should Avoid Cobicistat?
Bareback Guide 30 August 2026

Cobicistat is not chosen for its own sake; it is accepted as the price of the drug it boosts. Where that price is too high, the answer is usually a regimen that needs no booster at all.

Who is excluded by contraindicated medicines?

Anyone taking simvastatin, lovastatin, midazolam, triazolam, ergot derivatives or certain antiarrhythmics. The list is long enough that checking is essential rather than optional, and many entries have workable alternatives.

Who is excluded by enzyme inducers?

Anyone taking rifampicin, certain anticonvulsants or St John's wort. These defeat the boosting entirely, leaving the partner drug inadequate, which risks failure and resistance.

What about pregnancy?

Cobicistat-boosted regimens are generally avoided. Levels of both the booster and the boosted drug fall significantly in the later stages of pregnancy, potentially to inadequate concentrations. Anyone pregnant or planning a pregnancy on one should raise it early, since a switch is frequently recommended.

What about liver impairment?

Not recommended in severe hepatic impairment. Moderate impairment may be acceptable depending on the partner drug, and this is a clinical judgement rather than a fixed rule.

What about people using recreational drugs?

Not a prohibition and a genuine safety consideration. The raised levels of stimulants and ketamine on boosted regimens have caused deaths. Being honest about this changes the prescription, and clinics treat it as clinical information rather than a moral matter.

What about people on inhaled steroids?

Worth reviewing rather than ruling out. Some inhaled and nasal steroids interact far less than fluticasone, and switching the inhaler is frequently easier than switching the HIV regimen.

What about people taking many other medicines?

The group for whom boosted regimens are least suitable. Someone on several cardiac, psychiatric or respiratory medicines faces a cumulative interaction burden that an unboosted regimen simply avoids.

What about kidney function?

Cobicistat itself is not the problem, and the combination products containing tenofovir have thresholds. The expected creatinine rise also makes interpreting kidney function slightly harder, which is worth knowing rather than avoiding.

Is ritonavir a solution?

Rarely. Both boosters produce a very similar interaction profile, so switching between them improves comfort without solving the underlying problem. Removing the booster is what changes the picture.

What are the alternatives?

Unboosted integrase inhibitors, chiefly dolutegravir and bictegravir, which are first-line, need no booster and have short interaction lists. Doravirine among the non-nucleosides. These are the reason boosted regimens have become less common.

Can you switch away easily?

Usually. Switching from a boosted regimen to an unboosted integrase inhibitor is routine for people who are suppressed, and it typically simplifies everything else considerably.

Who decides?

You do, with a clinician. If the interaction burden is making your life difficult, that is a legitimate reason to ask for a change rather than something to absorb.

Is a second opinion reasonable?

Entirely. If you have been told cobicistat is your only option, or that you cannot change, asking to discuss it again or to see someone else is a normal part of care rather than a complaint about anyone.

What happens if you have to change?

Switching is routine and suppression is maintained provided the new regimen is fully active. Coming off cobicistat is not a setback and it does not narrow your options later, since most changes are reversible.

What should you bring to the conversation?

What is actually bothering you, in concrete terms, and what you would want instead if it were possible. That produces a more useful discussion than a general sense that something is not right.

Does avoiding it limit you later?

Rarely. Not taking cobicistat now does not rule it out in future, and it does not narrow the options available to you. Regimens are revisited regularly as circumstances change.

What if your circumstances change?

Regimens are revisited. Pregnancy, a new diagnosis, a new medicine, changing kidney function or simply a change in how you live can all make a different option better. Raising it is reasonable rather than difficult.